Galenica (XSWX:GALE) Ending Cash Position: CHF116 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:GALE Galenica Ltd XSWX:GALE
83 GF Score
Price CHF89.15
GF Value CHF86.37
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Galenica Ending Cash Position?

Galenica XSWX:GALE +0.79% 83 Ending Cash Position is CHF116 Mil as of Dec. 2025. GuruFocus rates XSWX:GALE with a GF Score™ of 83/100 and a GF Value™ of CHF86.37 (Fairly Valued). The stock has 1 warning sign investors should review.

Galenica's Ending Cash Position for the quarter that ended in Dec. 2025 was CHF116 Mil.

Galenica's quarterly Ending Cash Position declined from Dec. 2024 (CHF130 Mil) to Jun. 2025 (CHF67 Mil) but then increased from Jun. 2025 (CHF67 Mil) to Dec. 2025 (CHF116 Mil).

Galenica's annual Ending Cash Position increased from Dec. 2023 (CHF116 Mil) to Dec. 2024 (CHF130 Mil) but then declined from Dec. 2024 (CHF130 Mil) to Dec. 2025 (CHF116 Mil).

Galenica Ending Cash Position Related Terms

Galenica Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Galenica's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galenica Ending Cash Position Chart

Galenica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 164.98 93.93 116.16 129.68 115.51

Galenica Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.16 69.55 129.68 67.07 115.51
XSWX:GALE
83GF Score
Galenica Ltd XSWX:GALE
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galenica Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Galenica's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=129.681+-14.174
=116

Galenica's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=67.067+48.44
=116

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of CHF116 Mil mean?
Galenica (XSWX:GALE) has a Ending Cash Position of CHF116 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Galenica and its competitors.
Is Galenica's Ending Cash Position too high?
Galenica's current Ending Cash Position is CHF116 Mil. Overall, Galenica has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Galenica's Ending Cash Position compare to MCK and CAH?
Galenica's Ending Cash Position of CHF116 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Distribution company?
A good Ending Cash Position depends on the Medical Distribution industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Galenica and its competitors. Galenica's current Ending Cash Position is CHF116 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Based on GuruFocus' analysis, Galenica (XSWX:GALE) is currently considered Fairly Valued. The stock's GF Value™ is CHF86.37, compared to a current price of CHF89.15 — trading 3.2% above its estimated fair value. The current Ending Cash Position is CHF116 Mil. Galenica's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Galenica (XSWX:GALE), the current Ending Cash Position is CHF116 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Galenica (XSWX:GALE) Overvalued in 2026?

Based on GuruFocus' analysis, Galenica stock appears to be overvalued. The current stock price of CHF89.15 is trading 3.2% above its estimated GF Value™ of CHF86.37. GuruFocus considers Galenica to be Fairly Valued.

Key valuation signals for XSWX:GALE:

  • Ending Cash Position: CHF116 Mil
  • GF Value™: CHF86.37 vs. price of CHF89.15 (3.2% above fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the XSWX:GALE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Galenica Business Description

Address Untermattweg 8, Bern, CHE, CH-3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
83GF Score

Get the complete analysis for XSWX:GALE

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF89.15
Price
CHF86.37
GF Value